The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease
(2014) In Neurodegenerative disease management 4(4). p.297-307- Abstract
Cell-based therapies for Parkinson's and Huntington's disease have provided mixed clinical outcomes and one of the reasons underlying this is the use of primary fetal tissue as the source of grafted cells. An alternate source of cells, such as stem cells, could overcome many of the issues associated with primary fetal tissue and would help bring forward cell replacement therapy as a reliable and effective treatment for these two neurodegenerative disorders. This review will discuss which stem cells are likely to go to clinic in the next generation of cells, based on trials for Parkinson's and Huntington's disease.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/64628f33-5c97-4f0e-82ca-e8f93a5e65eb
- author
- Drouin-Ouellet, Janelle LU
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- keywords
- Cell- and Tissue-Based Therapy, Fetal Research, Fibroblasts, Humans, Huntington Disease, Neurodegenerative Diseases, Pluripotent Stem Cells, Stem Cell Transplantation, Tissue Engineering, Journal Article, Research Support, Non-U.S. Gov't, Review
- in
- Neurodegenerative disease management
- volume
- 4
- issue
- 4
- pages
- 11 pages
- publisher
- Future Medicine Ltd.
- external identifiers
-
- pmid:25313986
- scopus:84928699326
- ISSN
- 1758-2024
- DOI
- 10.2217/nmt.14.26
- language
- English
- LU publication?
- no
- id
- 64628f33-5c97-4f0e-82ca-e8f93a5e65eb
- date added to LUP
- 2016-11-22 09:02:41
- date last changed
- 2024-04-19 13:03:07
@article{64628f33-5c97-4f0e-82ca-e8f93a5e65eb, abstract = {{<p>Cell-based therapies for Parkinson's and Huntington's disease have provided mixed clinical outcomes and one of the reasons underlying this is the use of primary fetal tissue as the source of grafted cells. An alternate source of cells, such as stem cells, could overcome many of the issues associated with primary fetal tissue and would help bring forward cell replacement therapy as a reliable and effective treatment for these two neurodegenerative disorders. This review will discuss which stem cells are likely to go to clinic in the next generation of cells, based on trials for Parkinson's and Huntington's disease.</p>}}, author = {{Drouin-Ouellet, Janelle}}, issn = {{1758-2024}}, keywords = {{Cell- and Tissue-Based Therapy; Fetal Research; Fibroblasts; Humans; Huntington Disease; Neurodegenerative Diseases; Pluripotent Stem Cells; Stem Cell Transplantation; Tissue Engineering; Journal Article; Research Support, Non-U.S. Gov't; Review}}, language = {{eng}}, number = {{4}}, pages = {{297--307}}, publisher = {{Future Medicine Ltd.}}, series = {{Neurodegenerative disease management}}, title = {{The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease}}, url = {{http://dx.doi.org/10.2217/nmt.14.26}}, doi = {{10.2217/nmt.14.26}}, volume = {{4}}, year = {{2014}}, }